Biotechnologies Available for Licensing:
By Title

Available biotechnologies may also be viewed by type and application.

in vivo data availablein vivo data available

 

Title Tech ID #
SERCA2: Novel Target for the Treatment of Cystic Fibrosis 09-05
Adenosine A2A Receptor:  A Prognosis Marker for Lung Cancer 08-11
Novel TLR Inhibitors Reduce Lung Inflammation In Vivo  in vivo data available 07-07
Antibody against VGamma4 T Cells reduces Rheumatoid Arthritis symptoms in a mousein vivo data available 07-06
Knee aspirate facilitator 07-02
MAGP-2: An extracellular factor shown to have pro-angiogenic properties in vivo in vivo data available 06-05
Method to prevent biofilm formation in various clinical settings (contact lenses, wounds, cystic fibrosis, etc.)  04-08
Cystatin C: an extracellular antagonist of the TGF beta receptor. Potential therapies for cancer and fibrotic diseases 04-05
Be-Adducts and 10Be-Adduct Probes in the Diagnosis and Treatment of Disease 04-03
Method for identifying MHC-presented epitopes for T cells 03-01
Modulating the transport of thiol-containing molecules for the treatment of lung disease and cancerin vivo data available 02-16
Efficient method to produce mature neutrophils from embryonic stem cells 02-08
Liposomal clodronate as a therapy for autoimmune hemolytic anemiain vivo data available 02-07
High-throughput cell based assay for the identification of drugs targeting the NF-kB signaling pathway 02-05
Use of aerosolized anti-TCR monoclonal antibodies as a therapy for airway hyperresponsivenessin vivo data available 01-01
Calcitonin Gene-Related Peptide For The Reduction Of Allergen-Induced Airway Hyperresponsivenessin vivo data available 00-14
Cdk6 as a marker for breast cancer 00-11
New Agar Medium for the Isolation and Testing Susceptibility of Mycobacterium Tuberculosis Against Drugs 00-05
Novel molecular targets for anti-inflammatory drug development:
- TALL-1: A member of the TNF gene family
- TALL-1 receptor (BCMA)
- TALL-1 and receptors 3D structure 		00-01
Method for treating inflammatory diseases using heat shock proteinsin vivo data available 98-07
Anti-CD79 antibody offers novel approach to therapy in autoimmune disease, transplantation and lymphomain vivo data available 98-04
Thioredoxins for the treatment of lung diseasein vivo data available 96-07
Method to Identify Compounds Regulating Actin Polymerization  96-06
Peptides offer strategies for novel immunosuppressants and anti-herpes agents 96-02
Promising gene immunotherapy technology fights tumors and infectious diseasesin vivo data available 95-03
Method to Produce Monoclonal Antibodies to Human T-Cell Receptor Elements 91-02

 

Research Tools

View list of available Antibodies or Animal models.

 

Biomedical Devices

View list of available biomedical devices.

 

For more information, contact Emmanuel Hilaire at HilaireE@njhealth.org.


1-800-222-5864
Refer a Patient

Faculty by Research

The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease.

Browse our A-Z directory of Faculty by Area of Research.